Showing results (51-60 of 362) with videos related to

Sort By:
Pageof 37
Drug Safety|January 23, 2016
Maximizing the Post-Approval Safety of Flibanserin: A Role for Regulators, Clinicians, and PatientsSheriza N Baksh, Walid F Gellad, G Caleb Alexander
Medical Care|December 18, 2014
Construct validity and factor structure of survey-based assessment of cost-related medication burdenMehmet Burcu, G Caleb Alexander, Xinyi Ng, et al.
Psychiatric Services (Washington, D.C.)|August 26, 2020
Association of Pharmaceutical Industry Payments to Physicians With Prescription and Medicare Expenditures for PimavanserinHemalkumar B Mehta, Thomas J Moore, G Caleb Alexander
Annals of Internal Medicine|June 22, 2011
Enhancing prescription drug innovation and adoptionG Caleb Alexander, Alec B O'Connor, Randall S Stafford
Diabetes Care|January 28, 2010
Changes in glitazone use among office-based physicians in the U.S., 2003-2009Andrew Cohen, Atonu Rabbani, Nilay Shah, et al.
Archives of Internal Medicine|April 11, 2007
Physician consideration of patients' out-of-pocket costs in making common clinical decisionsHoangmai H Pham, G Caleb Alexander, Ann S O'Malley
BMC Health Services Research|December 1, 2012
Association between unemployment rates and prescription drug utilization in the United States, 2007-2010Daniel Kozman, Christopher Graziul, Robert Gibbons, et al.
JAMA Network Open|May 16, 2023
Patterns of Manufacturer Coupon Use for Prescription Drugs in the US, 2017-2019So-Yeon Kang, Angela Liu, Gerard Anderson, et al.
Medical Care|August 13, 2019
Chronic Disease Medication Adherence After Initiation of Buprenorphine for Opioid Use DisorderHsien-Yen Chang, Matthew Daubresse, Brendan Saloner, et al.
Pageof 37